{
    "2021-04-24": [
        [
            {
                "time": "",
                "original_text": "董承非独爱美年健康，葛兰剔除英科医疗，刘格菘连续重仓康泰生物，顶流明星医药思路不同",
                "features": {
                    "keywords": [
                        "董承非",
                        "美年健康",
                        "葛兰",
                        "英科医疗",
                        "刘格菘",
                        "康泰生物",
                        "医药"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "A股分化再起！基金高仓位不改，核心资产仍是风向？",
                "features": {
                    "keywords": [
                        "A股",
                        "分化",
                        "基金",
                        "高仓位",
                        "核心资产"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上市药企2020年报解码：谁大把花钱做销售推广？谁重金搞研发？",
                "features": {
                    "keywords": [
                        "上市药企",
                        "2020年报",
                        "销售推广",
                        "研发"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上市药企2020年报解码，医疗器械公司净利增幅大",
                "features": {
                    "keywords": [
                        "上市药企",
                        "2020年报",
                        "医疗器械",
                        "净利增幅"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "医疗器械"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "北向资金回流A股，创业板指周涨逾7%",
                "features": {
                    "keywords": [
                        "北向资金",
                        "回流",
                        "A股",
                        "创业板指",
                        "周涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}